Overview
Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together
Status:
Completed
Completed
Trial end date:
2013-05-01
2013-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Bioequivalence of an empagliflozin/metformin (FDC) tablet compared with single tablets of two strength of empagliflozin and metformin (Part I) under fasted and under fed conditions and bioequivalence of empagliflozin/metformin (FDC) tablet compared with single tablets empagliflozin and metformin under fed conditions (Part II).Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Boehringer IngelheimTreatments:
Empagliflozin
Metformin
Criteria
Inclusion criteria:1. Healthy male and female subjects
Exclusion criteria:
1. Any relevant deviation from healthy conditions